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A complex individual patient simulation model (UKPDS Outcome Model version
1.3) was used with quality adjusted life years (QALY) and cost of complications as
model outputs. To reduce 1st-order uncertainty, 1000 patients were simulated for
each input combination selected. ANN simulation meta-models using a sample of
200 individual runs were developed and cross-validated to approximate the origi-
nal simulation as these do not require any specific input-output functional rela-
tionship and can handle any number of input parameters. Performance was com-
pared with a Gaussian Process (GP) meta-model, and a valid and better predictive
meta-model was then used for PSA. RESULTS: From ANN meta-models, the mean
absolute percentage error (defined as positive difference between the predicted
and true output divided by the range in true output) was 3.8 % for costs and 1.4% for
QALYs compared with 5.1% and 2.1% in GP meta-models. The distribution of errors
was approximately symmetrical around zero meaning that mean costs and QALYs
for an intervention are unlikely to be affected by the small inaccuracies associated
with ANN approximations. CONCLUSIONS: ANN produces better predictive capa-
bility than GP meta-models in estimating costs and QALYs from the UKPDS out-
come model. A PSA carried out using the ANN meta-model demonstrated the po-
tential for ANN in analysing complex health economic models.
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OBJECTIVES:Different methods of meta-analysis on model parameters can lead to
different outcomes of cost-effectiveness (CE) modeling. As the “true” CE is un-
known, it is unclear which method performs best. We compared different methods
of meta-analysis with regards to the underlying “true” CE outcome. METHODS: In
a simulation study we constructed two patient populations and their treatments
(“truth”): a chronic disease with events and a progressive lethal disease. We drew
trials from these populations, comparing two treatments, varying the number of
trials, trial sizes and between-study heterogeneity in scenarios. From each trial
utilities, transition and event probabilities, risk-differences and log-risk-ratios
were estimated. These parameters were synthesized using frequentist fixed-ef-
fects (FFE) and random-effects (FRE), Bayesian fixed-effects (BFE) and random-ef-
fects (BRE) models. A CE model was filled and probabilistic sensitivity analysis was
performed. We repeated this trial sampling, leading to 1000 sets of health economic
outcomes for each scenario. We compared methods of meta-analysis on bias and
coverage, the percentage of draws that the “true” outcome lies in the confidence
interval. RESULTS: Even in the most heterogeneous scenario, biases were limited
to approximately 5%, and similar for all methods, but small biases in individual
treatment arms occasionally led to biases up to 30% in the difference between
arms. FFE models consistently have lower coverage than BFE. With homogeneous
trials, all methods have coverage above 80% for all outcomes. BRE has coverage
higher than 99% for all outcomes, regardless of heterogeneity. With heterogeneity,
RE methods perform better than FE and FRE has a lower coverage compared to BRE.
All methods, even with heterogeneous trials, have 100% coverage around the ICER.
CONCLUSIONS: BFE or BRE models are preferred in all situations, as they are more
conservative. However, insight in the real level of heterogeneity is important, as
using BRE without heterogeneity will overestimate uncertainty.
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OBJECTIVES: To develop a method which increases the potential to find statisti-
cally significant differences in costs and effects when a trial is powered using a
dichotomous outcome. METHODS: An example is used of a trial assessing an in-
tervention to prevent late pain. Treatment is expected to increase the percentage of
pain-free patients from 85% to 92%, giving a power of 80% with 500 patients. Using
EQ-5D as outcome decreases the power to 40%. We improve on this by deriving
T-tests in which the following assumptions are taken into consideration: 1. quality
of life with pain (8% vs 15%) is identical in both arms 2. quality of life without pain
(85% vs 92%) is identical in both arms Alternatively, we use a Bayesian approach
assuming that the differences between arms follow normal distributions with
mean zero and varying precision. Using simulations the frequentist and Bayesian
approach are linked and it is analysed to what extent the results depend on the
base line probabilities. RESULTS:Making both assumptions increases the power to
80% as in the binary assessment. Applying assumption 1 increases the power with
only 2%, applying assumption 2 increases it to almost 80%. When assuming that
the outcome is 44% versus 56% instead of 85% vs 92% both assumptions contribute
to the power approximately equally. The Bayesian model coincides with the as-
sumptions from the frequentist approach when the precision is set to the extremes
(zero or infinity). Between these it offers a flexible approach where the road from
one extreme to another is defined by cumulative normal distributions on the log of
the squared root of the precision. CONCLUSIONS: Traditional approaches may
disregard common sense. Building this into the analysis and the assessment of the
data will decrease suggested uncertainty and may decrease the need for large
patients numbers.
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OBJECTIVES: The use of registry databases and indirect comparisons has be-
come important in health economic evaluations. Lack of randomization could
lead to selection bias due to pretreatment differences between patients. To
control for selection bias, the propensity score method (PS) (Rosenbaum & Ru-
bin, 1983) is often applied. However, average treatment effects can vary within
different subgroups. It is yet unclear how to perform subgroups analyses when
the propensity score method is applied. METHODS: A Monte Carlo simulation is
conducted to test the performance of eight different forms of the PS in subgroup
analyses. The PSs differ in whether the variables included in the PS were indicators
of the subgroup and were related to treatment assignment, to outcome or related to
both assignment and outcome. Furthermore the PS is estimated in two ways, pri-
mary on treatment assignment only and secondly on a combination of the treat-
ment assignment and subgroup variable. These PSs were used as adjustment in a
regression model. Simulations are accomplished for 18 different settings varying
sample size, correlation between independent variables and correlation between
independent variables and subgroups. RESULTS: The PS without inclusion of the
variable for subgroups, but with inclusion of variables related to outcome, is the
most appropriate. The PS should be included as a covariate in a regression model
together with the variable for subgroups as covariate, where the PS is based on
treatment assignment only. Larger sample sizes gave less biased results, while a
higher correlation between the independent variables resulted in more biased es-
timates of the treatment and subgroup effect. Correlation between the indepen-
dent variables and the subgroup variable did not lead to biased results.
CONCLUSIONS: The results show the feasibility and validity of the PS in subgroups
analyses when analyzing registry databases and indirect comparisons in economic
evaluations.
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DESCRIBING THE SOCIETAL VALUE
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OBJECTIVES:Mood disorders are associated with a high societal cost, mainly due to
productivity loss and in particular presenteeism. The latter should therefore be
measured with the most appropriate tool. The objective is to review the use of ten
instruments in mood disorders and to provide recommendations about the most
appropriate instruments according to the situation. METHODS: A systematic re-
view was conducted using PubMed focusing on ten instruments: Endicott Work
Productivity Scale (EWPS), Health & Labour Questionnaire (HLQ), WHO Health and
Work Performance Questionnaire (HPQ), Health and Work Questionnaire (HWQ),
Lam Employment Absence and Productivity Scale (LEAPS), Sheehan Disability Scale
(SDS), Stanford Presenteeism Scale (SPS), Work and Health Interview (WHI), Work
Limitation Questionnaire (WLQ) and Work Productivity and Activity Impairment
(WPAI). Study characteristics and major results (by symptom level, by treatment
arm, correlation to other scales and use of monetisation) were extracted. RESULTS:
Twenty-nine studies (21 observational studies) were identified. No studies in mood
disorders were retrieved for two scales (HLQ and HWQ). SDS, WLQ and HPQ were
the most commonly used instruments. Most scales demonstrated higher presen-
teeism in patients with symptoms of mood disorders than in patients without.
LEAPS, SDS and WLQ showed increased presenteeism with increasing severity of
disease. Few studies reported results on presenteeism by treatment and no be-
tweentreatment differences were generally observed. Good correlations between
presenteeism instruments and clinical or quality of life scales were reported. Only
three studies converted results from presenteeism scales into monetary units.
CONCLUSIONS: Limited evidence exists to compare the performance of presentee-
ism scales in mood disorders. Recommendations for inclusion of a presenteeism
tool should be driven by theoretical arguments (ease of administration, amenabil-
ity to monetisation) and the study type. Future research should focus on the re-
sponsiveness demonstration and the evaluation of the impact of mood disorders
on self-reported assessment.
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OBJECTIVES: Many health economists consider applying the friction cost method
to estimate the productivity costs, but lack practical data and tools to apply the
method. This study aims to provide estimates for length of the friction period, cost
per working hour/day lost and friction costs for several European countries.
METHODS: Using national aggregate stock and flow time series data on vacancies,
we; 1) estimate vacancy durations for several European countries in order to esti-
mate the length of friction period, and 2) examine estimated vacancy durations
with unemployment and vacancy rates using regression analysis in order to check
the validity of estimated durations. Data for the price component for each country
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